Inhibition of PGE2/EP4 receptor signaling enhances oxaliplatin efficacy in resistant colon cancer cells through modulation of oxidative stress
Huakang Huang(Molecular Oncology (United States)), Daniel W. Rosenberg(Mayo Clinic)
Cited by 43
Related Papers
Suppression of colon carcinogenesis by targeting Notch signaling
|Carcinogenesis|2013|34